Synageva BioPharma Corp. (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced its presentation at the upcoming Cowen and Company 34th Annual Health Care Conference being held in Boston, MA. Synageva BioPharma Corp (NASDAQ:GEVA) stock opened at $109.72 in last session, and closed at $109.92, while the day range of Synageva BioPharma Corp (NASDAQ:GEVA) stock is $109.27 – $111.50. The stock showed a positive weekly performance of 10.83%.
Monster Beverage Corp (NASDAQ:MNST) to Report 2013 Fourth Quarter and Full Year Financial Results on February 27, 2014. Monster Beverage Corp (NASDAQ:MNST) stock opened at $75.16 in last session, and closed at $74.79 by gaining 0.12%. The 52 week range of $45.38 – $75.41. Company’s market capitalization is $12.52B.
Marvell Technology Group (NASDAQ:MRVL) announced a quarterly dividend on Friday, February 21st, Analyst Ratings Network reports. Shareholders of record on Thursday, March 13th will be paid a dividend of 0.06 per share on Thursday, March 27th. Marvell Technology Group Ltd. (NASDAQ:MRVL) stock decreased -3.26% and finished the last session at $15.60. The EPS of the stock remained 0.53. Company’s market capitalization is $7.67B.
Omeros Corporation, (NASDAQ:OMER) a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecules, has dosed its first patient in a second phase II clinical trial of OMS824, the company’s phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington’s disease (HD) and other cognitive disorders. Omeros Corporation (NASDAQ:OMER) stock opened the session at $14.22, and closed the session at $13.78. The 52 week range of the Omeros Corporation (NASDAQ:OMER) stock remained $3.65 – $14.68 and the day range was $13.75 – $14.68.